Highly meticulous and agile Bilingual Japanese Pharmaceutical Professional with a proven track record of balancing swift execution with absolute precision. Demonstrated expertise in managing high-impact accounts, interpreting intricate industry guidelines, and handling complex medical/scientific data for market leaders including IQVIA, Eli Lilly Japan, and Bristol Myers Squibb Japan. Adept at navigating rigid compliance frameworks, cross-functional stakeholder alignment, and error-free project coordination. Possesses deep context understanding and linguistic nuances in Japanese and English, fully prepared to leverage these highly transferable analytical and evaluative skills to deliver flawless, high-quality results as an AI Evaluation Specialist at Aura.
Secondment: Eli Lilly Japan
Secondment: Bristol Myers Squibb Japan
• New Business Development & Onboarding: Proactively targeted and customized outreach to diverse industries, successfully persuading organizations to pursue new ISO certifications (e.g., ISO 9001, ISO 14001) and providing end-to-end support through to successful implementation.
• Competitive Account Conversions: Spearheaded aggressive market-share expansion by targeting competitors' existing clients, articulating the superior value proposition, and successfully managing the account transition process.
• Meticulous & High-Speed Execution: Managed complex regulatory documentations, client communications, and transition timelines under tight schedules, maintaining a reputation for exceptionally fast, high-quality, and error-free execution.